Condition
Non ST Segment Elevation Acute Coronary Syndrome clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Non ST Segment Elevation Acute Coronary Syndrome clinical trials that are recruiting, at sites in 4 countries (most in China (2), Netherlands (1), Poland (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Non ST Segment Elevation Acute Coronary Syndrome clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Prehospital triage for intermediate- to high-risk NSTE-ACS using HEAR score and hs troponin | — | Haps and 2 other locations | Recruiting | Nov 26, 2025 |
| Using beetroot juice to prevent kidney damage during heart procedures | — | Cartagena | Recruiting | Nov 19, 2024 |
| Evaluating the impact of angiography-based FFR after heart procedures | — | Warsaw | Recruiting | Feb 13, 2024 |
| Using magnetocardiography to identify heart ischemia in patients with suspected NSTE-ACS | — | Jinan, Shandong | Recruiting | Jan 9, 2024 |
| Early Initiation of PCSK9 Inhibitor Tafolecimab in ACS Patients Undergoing PCI | Phase 4 | Beijing, Beijing Municipality and 1 other locations | Recruiting | Oct 24, 2023 |
All recruiting trials (5)
-
Prehospital triage for intermediate- to high-risk NSTE-ACS using HEAR score and hs troponin
This trial tests whether directing certain intermediate- to high-risk chest-pain patients straight to a PCI center can be faster and cost-effective while not increasing major heart events.
-
Using beetroot juice to prevent kidney damage during heart procedures
This study is testing if drinking beetroot juice can help protect the kidneys of patients at high risk for kidney damage during heart procedures.
-
Evaluating the impact of angiography-based FFR after heart procedures
This study is trying to see if measuring blood flow in heart arteries after a heart procedure can help predict serious heart problems and improve patients' quality of life.
-
Using magnetocardiography to identify heart ischemia in patients with suspected NSTE-ACS
This study is testing if a new heart scan using magnetocardiography can quickly and accurately find heart problems in people with chest pain suspected of having a type of heart attack.
-
Early Initiation of PCSK9 Inhibitor Tafolecimab in ACS Patients Undergoing PCI
This trial tests starting Tafolecimab early in people with acute coronary syndrome who are having PCI to lower bad cholesterol quickly and see if it reduces heart problems after discharge.
Related topics
Quick answers
How many Non ST Segment Elevation Acute Coronary Syndrome clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), Netherlands (1 trial), Poland (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.